Continuous Professional Development Clinical ... Hem Onc 2018... · • Discuss the approach to...

6
OMNI SCOTTSDALE RESORT AND SPA AT MONTELUCIA SCOTTSDALE, ARIZONA FEBRUARY 16–18, 2018 The 15th Annual Review HEMATOLOGY & ONCOLOGY Clinical Multidisciplinary CE.MAYO.EDU/HEMONC2018 Mayo Clinic School of Continuous Professional Development $75 DISCOUNT IF YOU REGISTER ON OR BEFORE JAN 5, 2018

Transcript of Continuous Professional Development Clinical ... Hem Onc 2018... · • Discuss the approach to...

OMNI SCOTTSDALE RESORT AND SPA AT MONTELUCIASCOTTSDALE, ARIZONAFEBRUARY 16–18, 2018

The 15th Annual Review

HEMATOLOGY & ONCOLOGY

Clinical Multidisciplinary

CE.MAYO.EDU/HEMONC2018

Mayo Clinic School of Continuous Professional Development

$75 DISCOUNTIF YOU REGISTER

ON OR BEFORE JAN 5, 2018

WELCOME RECEPTION Friday, February 16, 2018, 5:45 – 7:00 p.m. Attendees and guests are cordially invited to join course faculty at a Welcome Reception Friday, February 16, 2018 at 5:45 p.m. This casual reception welcomes you to the course and offers a perfect opportunity to meet existing and new colleagues. Pre-registration is requested.

COURSE HIGHLIGHTS• Comprehensive update and management strategies for key hematologic and

oncologic diseases

• New data and best practices for practicing physicians and the entire healthcare team

• Case and panel discussions

• Renowned guest and Mayo Clinic faculty

• Continuing education credit offered for physicians, pharmacists and nurses

TARGET AUDIENCEThis course is designed for physicians practicing in hematology and oncology, as well as physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in the diagnosis and treatment of patients with hematologic and oncologic disorders.

LEARNING OBJECTIVESUpon conclusion of this program, participants should be able to:

• List updates in key areas of clinical hematology, medical oncology, radiation oncology and surgical oncology.

• Review the latest advances in the management of HER2 positive breast cancer and triple negative breast cancer.

• Discuss the approach to perioperative therapy in hormone receptor positive breast cancer.

• Recognize the value of genomics in the treatment of colon cancer and define an approach to oligometastatic disease.

• Employ best practices in the management of metastatic gastric cancer.

• Identify an approach to the treatment of relapsed multiple myeloma and lymphoma in light of recently approved agents.

• Classify novel means of anticoagulation and the indications of newer agents.

• State the role of stem cell transplantation in hematological diseases.

• Define a clinical approach to the treatment of genitourinary malignancies.

• Cite the targeted approach to lung cancers and their challenges.

• Summarize best practices for the management of toxicity from immunotherapy.

• Integrate the many new advances in melanoma treatment into existing treatment paradigms.

• Review emerging therapies in sarcoma.

• Describe best practices in the multidisciplinary approach to head and neck cancers.

REGISTRATIONRegister online at:

Registration Fee On/Before Jan 5, 2018 After Jan 5, 2018

Physicians/Scientists $550 USD $625 USD

Fellows, Residents, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists

$275 USD $350 USD

Please visit ce.mayo.edu/cancellation for more information.

CE.MAYO.EDU/HEMONC2018

LODGING ACCOMMODATIONS Omni Scottsdale Resort & Spa at Montelucia 4949 East Lincoln Drive | Scottsdale, Arizona 85253 Reservations: (888) 627-3010 Online Reservations: https://www.omnihotels.com/hotels/scottsdale-montelucia/meetings/HemOnc2018

A special group rate of $299 (USD), per room per night, plus applicable city/state sales tax, single or double occupancy, is extended to course participants and guests. Group rates apply three days prior to and three days post-course dates, based upon availability. The resort charge has been waived and includes guest room internet, daily fitness center access, and self-parking.

Make your reservation before the room block fills or before January 19, 2018, via website, https://www.omnihotels.com/hotels/scottsdale-montelucia/meetings/HemOnc2018, or call (888) 627-3010 and reference Mayo Clinic Hematology and Oncology. Reservations will be taken following this date based upon room and rate availability.

Attendees are responsible for their own reservations. The standard hotel reservation cancellation policy will apply to individual reservations unless otherwise specified.

Mayo School of CPD is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.

PROGRAM

FRIDAY, FEBRUARY 16, 2018 6:45 a.m. Registration, Continental Breakfast and Exhibits 7:30 Welcome & Introductions SESSION 1: MYELOMA 7:45 Session 1-3 Pre-Test 8:00 Newly Diagnosed Myeloma 8:30 Relapsed Multiple Myeloma 9:00 Supportive Care Tips in Managing Multiple Myeloma 9:15 Question and Answer SessionSESSION 2: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 9:30 Approach to CLL Prognosis and Therapy in 201810:00 Oral Chemotherapy: A Pharmacist’s Perspective10:15 Question and Answer Session10:30 Refreshment Break and ExhibitsSESSION 3: LYMPHOMA11:00 Indolent Non-Hodgkin Lymphomas11:30 Risk Stratification and Management of Aggressive B-cell LymphomasNoon Question and Answer Session12:15 p.m. Session 1-3 Post-Test12:30 Lunch (provided)SESSION 4: SOLID TUMORS I 1:30 Session 4-5 Pre-Test 1:45 Precision Medicine in the Management of Colorectal Cancer 2:15 Oligometastatic Disease in Colon Cancer 2:45 Current and Emerging Treatment of Esophagogastric Cancer 3:15 Question and Answer Session 3:35 Refreshment Break and ExhibitsSESSION 5: SOLID TUMORS II 3:50 Continuing Advances in the Management of Metastatic Prostate Cancer 4:20 Bladder Cancer Treatment Update

Comprehensive program schedule at: CE.MAYO.EDU/HEMONC2018

4:50 Oral Chemotherapy Adherence 5:05 Question and Answer Session 5:25 Session 4-5 Post-Test 5:35 Adjourn 5:45 Welcome Reception

SATURDAY, FEBRUARY 17, 2018 6:45 a.m. Continental Breakfast and Exhibits 7:30 AnnouncementsSESSION 6: MYELOID 7:45 Session 6-7 Pre-Test 8:00 Life After Hydroxyurea: Managing MPNs in 2018 8:30 Acute Leukemia: New Therapy and Molecular Testing 9:00 Managing Patients with AML Receiving Therapy with Enasedenib 9:15 Question and Answer Session 9:30 Dharma, Happiness and Living with Purpose10:30 Refreshment Break and ExhibitsSESSION 7: BENIGN HEMATOLOGY11:00 Novel Anticoagulants in 201811:30 Thrombosis for the Oncologist: 2018 UpdateNoon Question and Answer Session12:15 p.m. Session 6-7 Post-Test12:30 Lunch (provided)SESSION 8: SOLID TUMORS III 1:30 Session 8-9 Pre-Test 1:45 Management of Advanced Melanoma 2:15 Management of Immune Related Toxicity from Checkpoint

Inhibitor Therapy 2:45 Question and Answer Session 3:05 Refreshment Break and ExhibitsSESSION 9: SOLID TUMORS IV 3:20 Ovarian Cancer: A Misunderstood Disease 3:50 How to Train the Immune System to Fight Chest Cancers: Current

Strategies and Ongoing Trials 4:20 Targeted Therapy in Lung Cancer 4:50 Benefits of Patient-Reported Outcomes for Symptom

Monitoring during Routine Cancer Treatment: Results of a Randomized Clinical Trial

5:05 Question and Answer Session 5:25 Session 8-9 Post-Test 5:35 Adjourn

SUNDAY, FEBRUARY 18, 2018 7:00 a.m. Continental Breakfast and Exhibits 7:45 AnnouncementsSESSION 10: SOLID TUMORS V 8:00 Session 10-11 Pre-Test 8:10 Multidisciplinary Management of Head and Neck Cancer 8:40 Sarcomas: Breakthroughs and Emerging Strategies 9:10 Question and Answer Session 9:30 Refreshment Break and ExhibitsSESSION 11: SOLID TUMORS VI 9:50 Perioperative Anti-Estrogen Therapy for Operable Breast Cancer10:20 Advances in HER2 Targeted Therapy10:50 Advances in TNBC11:20 Advances in Breast Imaging11:50 Question and Answer Session12:10 p.m. Session 10-11 Post-Test12:20 Closing Comments and Adjourn

FACULTYCourse DirectorsAlan H. Bryce, M.D. Joseph R. Mikhael, M.D., M.Ed., F.R.C.P.C.

Guest FacultySanjiv Chopra, M.D., M.A.C.P. Professor of Medicine Harvard Medical School James Tullis Firm Chief Department of Medicine Beth Israel Deaconess Medical Center Boston, Massachusetts

Rene Gonzalez, M.D., F.A.C.P. Professor of Medicine University of Colorado Denver Aurora, Colorado

Ruben A. Mesa, M.D., F.A.C.P. Director, UT Health San Antonio Cancer Center Mays Family Foundation Distinguished University Presidential Chair Professor of Medicine with Tenure San Antonio, Texas

Sonali M. Smith, M.D. Elwood V. Jensen Professor of Medicine Section of Hematology/Oncology Director, Lymphoma Program The University of Chicago Chicago, Illinois

Mayo Clinic Faculty Daniel H. Ahn, D.O.

Karen S. Anderson, M.D., Ph.D.

Tanios S. Bekaii-Saab, M.D., F.A.C.P.

Alan H. Bryce, M.D.

Kristina A. Butler, M.D., M.S.

Christopher B. Coughlin, Pharm.D., R.Ph.

Amylou C. Dueck, Ph.D.

Axel Grothey, M.D.

Tufia C. Haddad, M.D.

Neil E. Kay, M.D.

Emily A. Knight, A.P.R.N., M.S.N., N.P.

Lisa A. Kottschade, A.P.R.N., C.N.P.

Angela A. Mayo, P.A.-C., M.S.

Andrea L. McNatty, Pharm.D., R.Ph.

Joseph R. Mikhael, M.D., M.Ed., F.R.C.P.C.

Donald W. Northfelt, M.D., F.A.C.P.

Leslie J. Padrnos, M.D.

Harshita R. Paripati, M.D.

Bhavika Patel, M.D.

Samir H. Patel, M.D.

Rajiv K. Pruthi, M.B.B.S.

Allison C. Rosenthal, D.O.

Helen J. Ross, M.D.

Mahesh Seetharam, M.D., F.A.C.P.

Parminder Singh, M.D.

Lisa Z. Sproat, M.D., M.S.W.

Keith Stewart, M.B., Ch.B.

CREDIT In support of improving patient care, Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ACCME: Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE: Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 20.0 ACPE knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity. Participants must

complete the entire activity and are required to complete an online evaluation(s) to earn credit.

Visit the activity’s website for additional information regarding the ACPE credit offering.

ANCC: Participants can earn up to 20.0 ANCC nursing contact hours commensurate with the extent of their participation in the activity. Nurses should claim only the credit commensurate with the extent of their participation in the activity

AAFP: Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

AOA: This program has been submitted to the American Osteopathic Association for AOA Category 2-A.

Other Health Care Professionals: A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

MA

YO

CL

INIC

5777

Eas

t May

o B

oule

vard

Pho

enix

, Ariz

ona

8505

4E

mai

l: m

ca.c

me@

may

o.ed

uP

ho

ne:

(480

) 301

-458

0

©20

17 M

ayo

Foun

dat

ion

for

Med

ical

Ed

ucat

ion

and

Res

earc

h |

MC

8300

-54

May

o C

linic

Sch

ool o

f Con

tinuo

us P

rofe

ssio

nal D

evel

opm

ent u

ses

mul

tiple

mai

ling

lists

and

can

not a

lway

s el

imin

ate

dup

licat

ions

. If y

ou h

ave

rece

ived

mul

tiple

bro

chur

es, p

leas

e p

ost o

r sh

are

them

with

inte

rest

ed c

olle

ague

s.

OMNI

SCO

TTSD

ALE

RESO

RT A

ND S

PA A

T M

ONTE

LUCI

ASC

OTTS

DALE

, ARI

ZONA

FEBR

UARY

16

–18,

201

8

$75

DISC

OUNT

FOR

EAR

LY R

EGIS

TRAT

ION

(offe

r ex

pire

s Ja

nuar

y 5,

201

8)

CE.M

AYO.

EDU/

HEM

ONC2

018

The

15th

Ann

ual R

evie

w

HEM

ATOL

OGY

&

ONC

OLOG

Y

Clin

ical

Mul

tidis

cipl

inar

y